mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
4e-05 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
6e-05 |
mRNA |
Tamoxifen |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
8e-05 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.0001 |
mRNA |
Nutlin-3a (-) |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
GSK690693 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |